Biological characteristics of an immunoregulatory activity secreted by an autoreactive CD4+ T cell clone that suppresses autoimmune diabetes in non-obese diabetic mice

International Immunology

Volumn 8, Issue 5, 1996, Pages 689-699

  Tan, Kut Nie ^a,b   Min, Hong K ^a,b   Pan, Luying ^a,b   Ferrara, James L M ^a,b   Myrick, Kyl V ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Allogeneic mixed lymphocyte reaction; Cytokine; Insulin dependent diabetes mellitus; Non obese diabetic mice; Regulatory T lymphocyte; Syngeneic mixed lymphocyte reaction

Indexed keywords

CD4 ANTIGEN; CONCANAVALIN A; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4;

ANIMAL CELL; ARTICLE; AUTOIMMUNITY; DIABETES MELLITUS; IMMUNOREGULATION; LYMPHOCYTE CLONE; LYMPHOCYTE PROLIFERATION; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN LYMPHOCYTE; T LYMPHOCYTE;

EID: 0029871013     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/8.5.689     Document Type: Article

References (49)

1. Castano, L and Eisenbarth, G S 1990 Type I diabetes: a chronic autoimmune disease of human, mouse, and rat Annu Rev Immunol. 8:647.
2. Makino, S , Kunimoto, K , Muraoka, Y , Mizushima Y., Katagiri, K and Toochino, Y 1980 Breeding of a non-obese diabetic strain of mice. Exp Anim. 29 1
3. Leiter, E H 1993 The NOD mouse a model for analyzing the interplay between heredity and environment in development of autoimmune disease. ILAR News 35 4.
4. Bohme, J., Schuhbaur, B , Kanagawa, O., Benoist, C and Mathis, D 1990 MHC-linked protection from diabetes dissociated from clonal deletion of T cells Science 249 293.
5. Slattery, R. M , Miller, J F. A. P., Heath, W R and Charlton, B. 1993 Failure of a protective major histocompatibility complex class II molecule to delete autoreactive T cells in autoimmune diabetes Proc Natl Acad Sci USA 90 10808
6. Katz, J D , Wang, B , Haskins, K , Benoist C and Mathis, D 1993 Following a diabetogenic T cell from genesis to pathogenesis Cell 74:1089
7. a transgene prevents diabetes in nonobese diabetic mice by inducing regulatory T cells. Proc. Natl Acad. Sci. USA 90 9566.
8. Serreze, D V and Leiter, E H. 1988 Defective activation of T suppresor cell function in nonobese diabetic mice J Immunol. 140:3801
9. Serezze, D V Gaskins, H R and Leiter, E. H 1993 Defects in the differentiation and function of antigen presenting cells in NOD/ Lt mice J Immunol 150:2534
10. Serreze D V., Gaedeke, J and Leiter, E 1993 Haematopoetic stem-cell defects underlying abnormal macrophage development and maturation in NOD/Lt mice: defective regulation of cytokine receptors and protein kinase C Proc. Natl Acad Sci. USA 90 9625
11. Langmuir, P B., Bridgett, M M., Bothwell, A L and Crispe, I N. 1993 Bone marrow abnormalities in the non-obese diabetic mouse Int Immunol. 5 169
12. Zipris, D., Lazarus, A. H., Crow, A R , Hadzija M and Delovitch, T L 1991 Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice J Immunol 146 3763
13. Rapoport, M J , Jaramillo, A , Zipris, D , Lazarus, A H., Serreze, D. V., Leiter, E. H., Cyopick, P , Danska, J S. and Delovitch, T. L 1993 Interleukin 4 reverses T cell proliferate unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice J Exp Med. 178:87.
14. + β islet cell-reactive T cell clones that suppress autoimmune diabetes in nonobese diabetic mice J Exp Med. 182 87
15. Lantz M. Thysell, H. Nisson, E and Olson, I. 1991. On the binding of tumor necrosis factor (TNF) to heparin and the release in-vivo of the TNF-binding protein I by heparin. J. Clin Invest 88 2026
16. Lortat-Jacob, H. and Grimaud, J-A 1991 Interferon gamma c-terminal function, new working hypothesis Heparin sulfate and heparin new targets for IFN-gamma, protect, relax the cytokine and regulate the activity Cell. Mol Biol 37:253
17. McCaffrey, T A , Falcone, D. J and Du, B. 1992 Transforming growth factor β-1 is a heparin-binding protein, identification of putative heparin-binding regions and isolation of heparins with varying affinity for TGFβ-1. J. Cell Physiol. 152:430.
18. Chirgwin J M , Przybyla A. E., MacDonald, R J and Rutter, W. J 1979 Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18 5294
19. Cheng, S , Fockler, C , Barnes, W M. and Higuchi, R 1994 Effective amplification of long targets from cloned inserts and human genomic DNA. Proc Natl Acad. Sci USA 91 5695
20. Matzinger, P. 1991. The JAM test: a simple assay for DNA fragmentation and cell death J Immunol Methods 145 185
21. Mosmann, T. R and Coffman, R L 1989 TH1 and TH2 cells different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol 7 145
22. + T cells Annu Rev Immunol 12:635
23. Mason, D and Fowell, D 1992 T-cell subsets and autoimmunity Curr Opin Immunol 4 728
24. + T cells in the pathogenesis of organ-specific autoimmune diseases Immunol Today 16 34.
25. Katz, J D , Benoist, C and Mathis, D 1995 T helper cell subsets in insulin-dependent diabetes. Science 268 1185.
26. h2 subsets, paradigms lost? Immunol Today 16 374
27. Tanaka, T , Hu-Li J , Seder R A , Fazekas, D S G., B and Paul, W E 1993 Interleukin 4 suppresses interleukin 2 and interferon γ production by naive T cells stimulated by accessory cell-dependent receptor engagement. Proc Natl Acad. Sci USA 90 5914
28. h1 clones J Exp Med 170 2081
29. Swain, S L , Weinberg, A. D , English, M and Huston, G 1990 IL-4 and IFN-γ direct the development of distinct subsets of helper T cells Fedn Proc 4:2020
30. h2 responses in a murine model of cutaneous leishmaniasis J Immunol 147 3149
31. Lucas, P J , Negishi, I., Nakayama, K-I , Fields, L. E and Loh, D Y 1995 Naive CD28-deficient T cells can initiate but not sustain an in vitro antigen-specific immune response J. Immunol 154:5757
32. Freeman, G J., Boussiotis, V A , Anumanthan, A , Bernstein, G M , Ke, X -Y , Rennert, P D , Gray, G S , Gribben J G and Nadler, L M 1995 B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4 Immunity 2:523
33. Shahinian, A , Pfeffer, K , Lee, K P , Kundig, T M , Kishihara, K , Wakeham, A Kawai, K , Ohashi, P S , Thompson, C B and Mak, T W 1993 Differential T cell costimulatory requirements in CD28-deficient mice Science 261 609.
34. Green, J M , Noel, P J , Sperling, A I , Walunas T. L., Gray, G. S , Bluestone, J A and Thompson, C. B 1994 Absence of B7-dependent responses in CD28-deficient mice Immunity 1:501
35. Allison, J P 1994 CD28-B7 interactions in T-cell activation. Curr Opin. Immunol 6:414
36. Thompson, C B. 1995 Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation? Cell 81 979
37. Smith, J B and Knowlton, R. P 1979 Activation of suppressor T cells in human T cells responsive to autologous non-T cells. J Immunol 123 419.
38. Sakane, T. and Green, I 1979. Specificty and suppressor function of human T cells responsive to autologous non-T cells J. Immunol 123:419
39. Baxter, A G., Adams, M A and Mandel, T E 1989 Comparison of high-and-low diabetes incidence NOD mouse strains Diabetes 38:1296.
40. Lederman, M M , Ellner, J J. and Rodman, H M. 1981 Defective suppressor cell generation in juvenile diabetes. J. Immunol. 127:2051
41. Chandy, K G., Charles, A M , Kershnar, A , Buckingham, E., Waldeck, N and Gupta, S 1984 Autologous mixed lymphocyte reaction in man XV Cellular and molecular basis of deficient autologous mixed lymphocyte response in insulin-dependent diabetes mellitus J. Clin Immunol 4:424
42. Rasanen, L , Hyoty, H , Lehto, M , Kalleionemi O -P., Antonen, J , Huuponen, T , Karjaleinen, J and Leinikki, P 1988 Defective autologous mixed lymphocyte reaction in newly diagnosed type I diabetes mellitus Clin. Exp Immunol 71:471
43. Faustman, D., Li, X., Lin, H , Fu, Y , Eisenbarth, G , Avrch, J and Guo, J 1991 Linkage of faulty major histocompatibility complex class I to autoimmune diabetes Science 254 1756.
44. Glimcher, L H., Steinberg, A D , House, S. B. and Green, I 1980 The autologous mixed lymphocyte reaction in strains of mice with autoimmune disease J Immunol 125:1832.
45. Horn, J T and Talal, N 1982 Decreased syngeneic mixed lymphocyte reaction in autoimmune susceptible mice. Scand J. Immunol 15 195
46. Sakane, T , Steinberg, A D. and Green, I. 1978 Failure of autologous mixed lymphocyte reaction between T and non-T cells in patients with systemic lupus erythematosis. Proc. Natl Acad Sci USA 75:3464.
47. Takada, S., Ueda, S., Suzuki, N., Murakawa, Y., Hoshino, T., Green, I , Steinberg, A D , Horowitz, D. A and Sakane, T 1985. Abnormalities in autologous mixed lymphocyte reaction-activated immunologic processes in systemic lupus erythematosis and the possible correction by IL-2 Eur J Immunol. 15 262
48. Miyasaka, N , Saavezie, B , Pierce, D A , Daniels, T. E. and Talal, N 1980 Decreased autologous mixed lymphocyte reaction in Sjorgen's syndrome. J. Clin. Invest. 66 928.
49. Weksler, M. E., Moody, C E and Kozak, R W. 1981 The autologous mixed lymphocyte reaction. Adv Immunol 31 271